Aygen, Bilgehan, et al. “Real-World Efficacy, Safety, and Clinical Outcomes of Ombitasvir Paritaprevir Ritonavir ± Dasabuvir ± Ribavirin Combination Therapy in Patients With Hepatitis C Virus Genotype 1 or 4 Infection: The Turkey Experience Experience”. Turkish Journal of Gastroenterology, vol. 31, no. 4, Jan. 2020, pp. 305-17, doi:10.5152/tjg.2020.19197.